Evidence map›Paper›PMID 38337625›Full record

ReviewNutrients2024

The Roles of MicroRNAs in Asthma and Emerging Insights into the Effects of Vitamin D

Adrián Hernández-Díazcouder, Rodrigo Romero-Nava, Blanca E Del-Río-Navarro, Fausto Sánchez-Muñoz, Carlos A Guzmán-Martín, Nayely Reyes-Noriega, Octavio Rodríguez-Cortés, José J Leija-Martínez, Juan Manuel Vélez-Reséndiz, Santiago Villafaña and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Connecting the Dots: How MicroRNAs Link Asthma and Atherosclerosis.International journal of molecular sciences · 2025
    Review
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Adrián Hernández-DíazcouderLaboratorio de Investigación de Obesidad y Asma, Hospital Infantil de México Federico Gómez, Ciudad de Mexico 06720, Mexico.ORCID 0000-0001-6569-2851
Rodrigo Romero-NavaLaboratorio de Señalización Intracelular, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de Mexico 11340, Mexico.ORCID 0000-0002-8429-5736
Blanca E Del-Río-NavarroServicio de Alergia e Inmunología, Hospital Infantil de México Federico Gómez, Ciudad de Mexico 06720, Mexico.ORCID 0000-0001-6441-8869
Fausto Sánchez-MuñozDepartamento de Inmunología, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de Mexico 14080, Mexico.ORCID 0000-0001-6556-1632
Carlos A Guzmán-MartínDepartamento de Inmunología, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de Mexico 14080, Mexico.ORCID 0000-0001-7365-9023
Nayely Reyes-NoriegaLaboratorio de Investigación de Obesidad y Asma, Hospital Infantil de México Federico Gómez, Ciudad de Mexico 06720, Mexico.ORCID 0000-0002-1701-7517
Octavio Rodríguez-CortésLaboratorio de Inflamación y Obesidad, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de Mexico 11340, Mexico.
José J Leija-MartínezCentro de Investigación en Ciencias de la Salud y Biomedicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí 78290, Mexico.ORCID 0000-0002-7178-1786
Juan Manuel Vélez-ReséndizLaboratorio Multidisciplinario de Nanomedicina y de Farmacología Cardiovascular, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de Mexico 11340, Mexico.ORCID 0000-0001-5278-620X
Santiago VillafañaLaboratorio de Señalización Intracelular, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de Mexico 11340, Mexico.
Enrique HongDepartamento de Farmacobiología, Centro de Investigación y Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de Mexico 14330, Mexico.
Fengyang HuangLaboratorio de Investigación de Obesidad y Asma, Hospital Infantil de México Federico Gómez, Ciudad de Mexico 06720, Mexico.ORCID 0000-0002-6503-694X
Instituto Politécnico Nacional · MXHospital Infantil de México Federico Gómez · MXInstituto Nacional de Cardiología · MXAutonomous University of San Luis Potosí · MXMexican Social Security Institute · MX

Funding

Mexican government for the Children's Hospital of Mexico Federico Gomez HIM/2021/023.SSa.1748, HIM/2022/044.SSa.1809 and HIM/2023/015 SSA 1857.
6 · The paper itself

Abstract

Asthma is one of the most common chronic non-communicable diseases worldwide, characterized by variable airflow limitation secondary to airway narrowing, airway wall thickening, and increased mucus resulting from chronic inflammation and airway remodeling. Current epidemiological studies reported that hypovitaminosis D is frequent in patients with asthma and is associated with worsening the disease and that supplementation with vitamin D

Indexed as

AsthmaMicroRNAsAirway RemodelingCholecalciferolDietary SupplementsHumansInflammationLungCholecalciferolMicroRNAsMIRN145 microRNA, humanasthmainflammationmicroRNAsvitamin D3 supplementation

Identifiers

PMID38337625
PMCPMC10856766
OpenAlexW4391169456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.